FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maria Masucci

Research Profile

Living Beings

Human Herpesvirus 4

Chemicals & Drugs

Anatomy

Disorders

Burkitt's Lymphoma

Physiology

Co-author Network

Publications

TOP 3
Giuseppe Coppotelli; Nouman Mughal; Diego Marescotti; Maria Masucci
High avidity binding to DNA protects ubiquitylated substrates from proteasomal degradation.
S A Kamranvar; Maria Masucci
The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress.
Eugénie Bassères; Giuseppe Coppotelli; Thorsten Pfirrmann; Jens B Andersen; Maria Masucci; Teresa Frisan
The ubiquitin C-terminal hydrolase UCH-L1 promotes bacterial invasion by altering the dynamics of the actin cytoskeleton.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maria Masucci (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Giuseppe Coppotelli; Nouman Mughal; Diego Marescotti; Maria Masucci
High avidity binding to DNA protects ubiquitylated substrates from proteasomal degradation.
The Journal of biological chemistry 2011;286(22):19565-75.
2011: S A Kamranvar; Maria Masucci
The Epstein-Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress.
Leukemia 2011;25(6):1017-25.
2010: Eugénie Bassères; Giuseppe Coppotelli; Thorsten Pfirrmann; Jens B Andersen; Maria Masucci; Teresa Frisan
The ubiquitin C-terminal hydrolase UCH-L1 promotes bacterial invasion by altering the dynamics of the actin cytoskeleton.
Cellular microbiology 2010;12(11):1622-33.
2010: Ramakrishna Sompallae; Simone Callegari; Siamak Akbari Kamranvar; Maria Masucci
Transcription profiling of Epstein-Barr virus nuclear antigen (EBNA)-1 expressing cells suggests targeting of chromatin remodeling complexes.
PloS one 2010;5(8):e12052.
2009: Bettina Gruhne; Siamak Akbari Kamranvar; Maria Masucci; Ramakrishna Sompallae
EBV and genomic instability--a new look at the role of the virus in the pathogenesis of Burkitt's lymphoma.
Seminars in cancer biology 2009;19(6):394-400.
2009: B Gruhne; Ramakrishna Sompallae; Maria Masucci
Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints.
Oncogene 2009;28(45):3997-4008.
2008: G Preta; Diego Marescotti; Cinzia Fortini; P Carcoforo; C Castelli; Maria Masucci; R Gavioli
Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.
Scandinavian journal of immunology 2008;68(6):579-88.
2008: Ramakrishna Sompallae; Stefano Gastaldello; Sebastian Hildebrand; Nikolay Zinin; Gerco Hassink; Kristina Lindsten; Juergen Haas; Bengt Persson; Maria Masucci
Epstein-barr virus encodes three bona fide ubiquitin-specific proteases.
Journal of virology 2008;82(21):10477-86.
2008: Lina Guerra; Heather S Carr; Agneta Richter-Dahlfors; Maria Masucci; Monica Thelestam; Jeffrey A Frost; Teresa Frisan
A bacterial cytotoxin identifies the RhoA exchange factor Net1 as a key effector in the response to DNA damage.
PloS one 2008;3(5):e2254.
2007: Jiang Li; Xiao-Shi Zhang; Dan Xie; Hai-Xia Deng; Yan-Fang Gao; Qiu-Yan Chen; Wen-Lin Huang; Maria Masucci; Yi-Xin Zeng
Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.
Cancer biology & therapy 2007;6(12):1997-2004.
2007: Ji-Yan Liu; Yang Wu; Xiao-Shi Zhang; Jin-Liang Yang; Hong-Li Li; Yong-Qiu Mao; Yi Wang; Xia Cheng; Yong-Qiang Li; Jian-Chuan Xia; Maria Masucci; Yi-Xin Zeng
Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine.
Cancer immunology, immunotherapy : CII 2007;56(10):1597-604.
2007: S A Kamranvar; B Gruhne; A Szeles; Maria Masucci
Epstein-Barr virus promotes genomic instability in Burkitt's lymphoma.
Oncogene 2007;26(35):5115-23.
2007: Jiang Li; Xue-hui Zeng; Hao-Yuan Mo; Ulrika Rolén; Yan-fang Gao; Xiao-Shi Zhang; Qiu-Yan Chen; Li Zhang; Mu-Sheng Zeng; Man-Zhi Li; Wen-Lin Huang; Xiao-ning Wang; Yi-Xin Zeng; Maria Masucci
Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy.
PloS one 2007;2(11):e1122.
2006: Michael Uhlin; Maria Masucci; Victor Levitsky
Is the activity of partially agonistic MHC:peptide ligands dependent on the quality of immunological help?
Scandinavian journal of immunology 2006;64(6):581-7.
2006: Vaia Stavropoulou; Vanessa Vasquez; Biancastella Cereser; Elio Freda; Maria Masucci
TPPII promotes genetic instability by allowing the escape from apoptosis of cells with activated mitotic checkpoints.
Biochemical and biophysical research communications 2006;346(2):415-25.
2006: Kristina Lindsten; Victoria Menéndez-Benito; Maria Masucci; Nico P Dantuma; Asangi R K Kumarapeli; Kathleen M Horak; Hanqiao Zheng; Xuejun Wang
GFP reporter mouse models of UPS proteolytic function.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(7):1027; author reply 1027-8.
2006: Tat'ána Majerová-Uhlíková; Nico P Dantuma; Kristina Lindsten; Maria Masucci; Jan Konvalinka
Non-infectious fluorimetric assay for phenotyping of drug-resistant HIV proteinase mutants.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;36(1):50-9.
2006: Ulrika Rolén; Vera Kobzeva; Natalja Gasparjan; Huib Ovaa; Gösta Winberg; Fjodor Kisseljov; Maria Masucci
Activity profiling of deubiquitinating enzymes in cervical carcinoma biopsies and cell lines.
Molecular carcinogenesis 2006;45(4):260-9.
2006: Anna Bosch-Comas; Kristina Lindsten; Roser Gonzàlez-Duarte; Maria Masucci; Gemma Marfany
The ubiquitin-specific protease USP25 interacts with three sarcomeric proteins.
Cellular and molecular life sciences : CMLS 2006;63(6):723-34.
2005: Michael Uhlin; Elena Sandalova; Maria Masucci; Victor Levitsky
Help signals provided by lymphokines modulate the activation and apoptotic programs induced by partially agonistic peptides in specific cytotoxic T lymphocytes.
European journal of immunology 2005;35(10):2929-39.
2005: Victoria Menéndez-Benito; Lisette G G C Verhoef; Maria Masucci; Nico P Dantuma
Endoplasmic reticulum stress compromises the ubiquitin-proteasome system.
Human molecular genetics 2005;14(19):2787-99.
2005: Michael Uhlin; Maria Masucci; Victor Levitsky
Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(26):9264-9.
2005: Stijn Heessen; Maria Masucci; Nico P Dantuma
The UBA2 domain functions as an intrinsic stabilization signal that protects Rad23 from proteasomal degradation.
Molecular cell 2005;18(2):225-35.
2005: Vaia Stavropoulou; Jianjun Xie; Marie Henriksson; Birgitta Tomkinson; Stefan Imreh; Maria Masucci
Mitotic infidelity and centrosome duplication errors in cells overexpressing tripeptidyl-peptidase II.
Cancer research 2005;65(4):1361-8.
2005: Sara Sundström; Seisuke Ota; Lina Dimberg; Maria Masucci; Anders Bergqvist
Hepatitis C virus core protein induces an anergic state characterized by decreased interleukin-2 production and perturbation of mitogen-activated protein kinase responses.
Journal of virology 2005;79(4):2230-9.
2004: A Cartier; Maria Masucci
Differential regulation of MHC class-I-restricted and unrestricted cytotoxicity by the Us3 protein kinase of herpes simplex virus-1.
Scandinavian journal of immunology 2004;60(6):592-9.
2004: Natalia Issaeva; Przemyslaw Bozko; Martin Enge; Marina Protopopova; Lisette G G C Verhoef; Maria Masucci; Aladdin Pramanik; Galina Selivanova
Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors.
Nature medicine 2004;10(12):1321-8.
2004: Andre Ortlieb Guerreiro-Cacais; LiQi Li; Daria Donati; Maria Teresa Bejarano; Andrew Morgan; Maria Masucci; Lindsey Hutt-Fletcher; Victor Levitsky
Capacity of Epstein-Barr virus to infect monocytes and inhibit their development into dendritic cells is affected by the cell type supporting virus replication.
The Journal of general virology 2004;85(Pt 10):2767-78.
2004: Daorong Liu; Charlotte Tammik; Jie-Zhi Zou; Ingemar Ernberg; Maria Masucci; Olle Ringden; Victor Levitsky
Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein-Barr virus load in the peripheral blood of bone marrow transplant recipients.
Clinical transplantation 2004;18(5):518-24.
2004: Maria Masucci
Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system.
Oncogene 2004;23(11):2107-15.
2004: Elena Sandalova; Cheng-Hong Wei; Maria Masucci; Victor Levitsky
Regulation of expression of Bcl-2 protein family member Bim by T cell receptor triggering.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(9):3011-6.
2004: Huib Ovaa; Benedikt M Kessler; Ulrika Rolén; Paul J Galardy; Hidde L Ploegh; Maria Masucci
Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(8):2253-8.
2003: Stijn Heessen; Nico P Dantuma; Peter Tessarz; Marianne Jellne; Maria Masucci
Inhibition of ubiquitin/proteasome-dependent proteolysis in Saccharomyces cerevisiae by a Gly-Ala repeat.
FEBS letters 2003;555(2):397-404.
2003: A Cartier; E Broberg; T Komai; M Henriksson; Maria Masucci
The herpes simplex virus-1 Us3 protein kinase blocks CD8T cell lysis by preventing the cleavage of Bid by granzyme B.
Cell death and differentiation 2003;10(12):1320-8.
2003: Anna Cartier; Tomoaki Komai; Maria Masucci
The Us3 protein kinase of herpes simplex virus 1 blocks apoptosis and induces phosporylation of the Bcl-2 family member Bad.
Experimental cell research 2003;291(1):242-50.
2003: Kristina Lindsten; Victoria Menéndez-Benito; Maria Masucci; Nico P Dantuma
A transgenic mouse model of the ubiquitin/proteasome system.
Nature biotechnology 2003;21(8):897-902.
2003: Riccardo Dolcetti; Maria Masucci
Epstein-Barr virus: induction and control of cell transformation.
Journal of cellular physiology 2003;196(2):207-18.
2003: Anders Bergqvist; Sara Sundström; Lina Dimberg; Erik Gylfe; Maria Masucci
The hepatitis C virus core protein modulates T cell responses by inducing spontaneous and altering T-cell receptor-triggered Ca2+ oscillations.
The Journal of biological chemistry 2003;278(21):18877-83.
2003: Farideh Sabri; Francesca Chiodi; Jean-Pascal Piret; Cheng-Hong Wei; Eugene Major; Bengt Westermark; Maria Masucci; Victor Levitsky
Soluble factors released by virus specific activated cytotoxic T-lymphocytes induce apoptotic death of astroglioma cell lines.
Brain pathology (Zurich, Switzerland) 2003;13(2):165-75.
2003: Michael Uhlin; Maria Masucci; Victor Levitsky
Pharmacological disintegration of lipid rafts decreases specific tetramer binding and disrupts the CD3 complex and CD8 heterodimer in human cytotoxic T lymphocytes.
Scandinavian journal of immunology 2003;57(2):99-106.
2003: Nico P Dantuma; Maria Masucci
The ubiquitin/proteasome system in Epstein-Barr virus latency and associated malignancies.
Seminars in cancer biology 2003;13(1):69-76.
2002: Riccardo Gavioli; Silvia Vertuani; Maria Masucci
Proteasome inhibitors reconstitute the presentation of cytotoxic T-cell epitopes in Epstein-Barr virus-associated tumors.
International journal of cancer. Journal international du cancer 2002;101(6):532-8.
2002: Lisette G G C Verhoef; Kristina Lindsten; Maria Masucci; Nico P Dantuma
Aggregate formation inhibits proteasomal degradation of polyglutamine proteins.
Human molecular genetics 2002;11(22):2689-700.
2002: Nico P Dantuma; Maria Masucci
Stabilization signals: a novel regulatory mechanism in the ubiquitin/proteasome system.
FEBS letters 2002;529(1):22-6.
2002: Cheng-Hong Wei; Michael Uhlin; Maria Masucci; Victor Levitsky
Tetramer binding and secretion of interferon-gamma in response to antigenic stimulation are compatible with a range of affinities of MHC:TCR interaction and distinct programs of cytotoxic T-lymphocyte activation.
Human immunology 2002;63(10):821-33.
2002: Victor Levitsky; Maria Masucci
Manipulation of immune responses by Epstein-Barr virus.
Virus research 2002;88(1-2):71-86.
2002: Ainars Leonchiks; Vaya Stavropoulou; Anatoly Sharipo; Maria Masucci
Inhibition of ubiquitin-dependent proteolysis by a synthetic glycine-alanine repeat peptide that mimics an inhibitory viral sequence.
FEBS letters 2002;522(1-3):93-8.
2002: LiQi Li; Daorong Liu; Lindsey Hutt-Fletcher; Andrew Morgan; Maria Masucci; Victor Levitsky
Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4.
Blood 2002;99(10):3725-34.
2002: Kristina Lindsten; Femke De Vrij; Lisette G G C Verhoef; David F Fischer; Fijs W B van Leeuwen; Elly M Hol; Maria Masucci; Nico P Dantuma
Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation.
The Journal of cell biology 2002;157(3):417-27.
2002: Martin Staege; Steven P Lee; Teresa Frisan; Josef Mautner; Siegfried Scholz; Alexander Pajic; Alan B Rickinson; Maria Masucci; Axel Polack; Georg W Bornkamm
MYC overexpression imposes a nonimmunogenic phenotype on Epstein-Barr virus-infected B cells.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(7):4550-5.
2002: Stijn Heessen; Ainars Leonchiks; Natalia Issaeva; Anatoly Sharipo; Galina Selivanova; Maria Masucci; Nico P Dantuma
Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(3):1532-7.
2002: LiQi Li; Anatoly Sharipo; Esteban Chaves-Olarte; Maria Masucci; Victor Levitsky; Monica Thelestam; Teresa Frisan
The Haemophilus ducreyi cytolethal distending toxin activates sensors of DNA damage and repair complexes in proliferating and non-proliferating cells.
Cellular microbiology 2002;4(2):87-99.
2002: Nico P Dantuma; Anatoly Sharipo; Maria Masucci
Avoiding proteasomal processing: the case of EBNA1.
Current topics in microbiology and immunology 2002;269():23-36.
2001: Kristina Lindsten; Tána Uhlíková; Jan Konvalinka; Maria Masucci; Nico P Dantuma
Cell-based fluorescence assay for human immunodeficiency virus type 1 protease activity.
Antimicrobial agents and chemotherapy 2001;45(9):2616-22.
2001: Anatoly Sharipo; Marta P Imreh; Ainars Leonchiks; C Brändén; Maria Masucci
cis-Inhibition of proteasomal degradation by viral repeats: impact of length and amino acid composition.
FEBS letters 2001;499(1-2):137-42.
2001: Riccardo Gavioli; Teresa Frisan; Silvia Vertuani; Georg W Bornkamm; Maria Masucci
c-myc overexpression activates alternative pathways for intracellular proteolysis in lymphoma cells.
Nature cell biology 2001;3(3):283-8.
2001: Cheng-Hong Wei; H Yagita; Maria Masucci; Victor Levitsky
Different programs of activation-induced cell death are triggered in mature activated CTL by immunogenic and partially agonistic peptide ligands.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(2):989-95.
2001: Teresa Frisan; Victor Levitsky; Maria Masucci
Limiting dilution assay.
Methods in molecular biology (Clifton, N.J.) 2001;174():213-6.
2001: Victor Levitsky; Teresa Frisan; Maria Masucci
Determination of antigen and fine peptide specificity of EBV-specific CTLs.
Methods in molecular biology (Clifton, N.J.) 2001;174():209-11.
2001: Victor Levitsky; Teresa Frisan; Maria Masucci
Generation of polyclonal EBV-specific CTL cultures and clones.
Methods in molecular biology (Clifton, N.J.) 2001;174():203-8.
2001: Teresa Frisan; Victor Levitsky; Maria Masucci
Regression assay.
Methods in molecular biology (Clifton, N.J.) 2001;174():199-201.
2001: Teresa Frisan; Victor Levitsky; Maria Masucci
Generation of lymphoblastoid cell lines (LCLs).
Methods in molecular biology (Clifton, N.J.) 2001;174():125-7.
2000: Teresa Frisan; Victor Levitsky; Maria Masucci
Variations in proteasome subunit composition and enzymatic activity in B-lymphoma lines and normal B cells.
International journal of cancer. Journal international du cancer 2000;88(6):881-8.
2000: Victor Levitsky; D Liu; Scott Southwood; Jelena Levitskaya; Alessandro Sette; Maria Masucci
Supermotif peptide binding and degeneracy of MHC: peptide recognition in an EBV peptide-specific CTL response with highly restricted TCR usage.
Human immunology 2000;61(10):972-84.
2000: S Aviel; G Winberg; Maria Masucci; Aaron Ciechanover
Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue.
The Journal of biological chemistry 2000;275(31):23491-9.
2000: Nico P Dantuma; Stijn Heessen; Kristina Lindsten; Marianne Jellne; Maria Masucci
Inhibition of proteasomal degradation by the gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(15):8381-5.
2000: Nico P Dantuma; Kristina Lindsten; Rickard Glas; Marianne Jellne; Maria Masucci
Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells.
Nature biotechnology 2000;18(5):538-43.
2000: L Li; Maria Masucci; Victor Levitsky
Effect of interleukin-7 on the in vitro development and maturation of monocyte derived human dendritic cells.
Scandinavian journal of immunology 2000;51(4):361-71.
2000: A Gustafsson; Victor Levitsky; Jie-Zhi Zou; Teresa Frisan; Tina Dalianis; Per Ljungman; Olle Ringden; Jacek Winiarski; Ingemar Ernberg; Maria Masucci
Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells.
Blood 2000;95(3):807-14.
1999: Teresa Frisan; Daria Donati; L Cervenak; J Wilson; Maria Masucci; Maria Teresa Bejarano
CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines.
International journal of cancer. Journal international du cancer 1999;83(6):772-9.
1999: Cheng-Hong Wei; Craig Beeson; Maria Masucci; Victor Levitsky
A partially agonistic peptide acts as a selective inducer of apoptosis in CD8+ CTLs.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(5):2601-9.
1999: E Reali; Remo Guerrini; Mauro Marastoni; Roberto Tomatis; Maria Masucci; Serena Traniello; Riccardo Gavioli
A single specific amino acid residue in peptide antigens is sufficient to activate memory CTL: potential role of cross-reactive peptides in memory T cell maintenance.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(1):106-13.
1998: Ainars Leonchiks; Edvards Liepinsh; M Barishev; Anatoly Sharipo; Maria Masucci; Gottfried Otting
Random coil conformation of a Gly/Ala-rich insert in IkappaB alpha excludes structural stabilization as the mechanism for protection against proteasomal degradation.
FEBS letters 1998;440(3):365-9.
1998: Maria Teresa Bejarano; Maria Masucci
Interleukin-10 abrogates the inhibition of Epstein-Barr virus-induced B-cell transformation by memory T-cell responses.
Blood 1998;92(11):4256-62.
1998: Anatoly Sharipo; Marta P Imreh; Ainars Leonchiks; Stefan Imreh; Maria Masucci
A minimal glycine-alanine repeat prevents the interaction of ubiquitinated I kappaB alpha with the proteasome: a new mechanism for selective inhibition of proteolysis.
Nature medicine 1998;4(8):939-44.
1998: Victor Levitsky; P O de Campos-Lima; Teresa Frisan; Maria Masucci
The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(2):594-601.
1998: Teresa Frisan; Victor Levitsky; Axel Polack; Maria Masucci
Phenotype-dependent differences in proteasome subunit composition and cleavage specificity in B cell lines.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(7):3281-9.
1998: Riccardo Gavioli; Remo Guerrini; Maria Masucci; Roberto Tomatis; Serena Traniello; Mauro Marastoni
High structural side chain specificity required at the second position of immunogenic peptides to obtain stable MHC/peptide complexes.
FEBS letters 1998;421(2):95-9.
1997: Victor Levitsky; Q J Zhang; Jelena Levitskaya; Michael Kurilla; Maria Masucci
Natural variants of the immunodominant HLA A11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I:peptide complexes.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(11):5383-90.
1997: Jelena Levitskaya; Anatoly Sharipo; Ainars Leonchiks; Aaron Ciechanover; Maria Masucci
Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(23):12616-21.
1997: P O Campos-Lima; Victor Levitsky; Marta P Imreh; Riccardo Gavioli; Maria Masucci
Epitope-dependent selection of highly restricted or diverse T cell receptor repertoires in response to persistent infection by Epstein-Barr virus.
The Journal of experimental medicine 1997;186(1):83-9.
1996: Teresa Frisan; Q J Zhang; Jelena Levitskaya; M Coram; Michael Kurilla; Maria Masucci
Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells.
International journal of cancer. Journal international du cancer 1996;68(2):251-8.
1996: Riccardo Gavioli; Q J Zhang; Maria Masucci
HLA-A11-mediated protection from NK cell-mediated lysis: role of HLA-A11-presented peptides.
Human immunology 1996;49(1):1-12.
1996: E Reali; Remo Guerrini; B Giori; M Borghi; Mauro Marastoni; Roberto Tomatis; Serena Traniello; Maria Masucci; Riccardo Gavioli
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides.
Clinical and experimental immunology 1996;105(2):369-75.
1996: Q J Zhang; Ylva Lindqvist; Victor Levitsky; Maria Masucci
Solvent exposed side chains of peptides bound to HLA A*1101 have similar effects on the reactivity of alloantibodies and specific TCR.
International immunology 1996;8(6):927-38.
1996: Victor Levitsky; Q J Zhang; Jelena Levitskaya; Maria Masucci
The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4.
The Journal of experimental medicine 1996;183(3):915-26.
1995: Riccardo Dolcetti; Teresa Frisan; Jan Sjöberg; P O De Campos-Lima; Pavel Pisa; Valli De Re; A Gloghini; Silvana Rizzo; Maria Masucci; Mauro Boiocchi
Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Cancer research 1995;55(16):3675-81.
1995: Marta P Imreh; Q J Zhang; P O de Campos-Lima; Stefan Imreh; P Krausa; M Browning; George Klein; Maria Masucci
Mechanisms of allele-selective down-regulation of HLA class I in Burkitt's lymphoma.
International journal of cancer. Journal international du cancer 1995;62(1):90-6.
1995: Jelena Levitskaya; M Coram; Victor Levitsky; S Imreh; P M Steigerwald-Mullen; George Klein; Michael Kurilla; Maria Masucci
Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.
Nature 1995;375(6533):685-8.
1995: Riccardo Gavioli; Q J Zhang; Mauro Marastoni; Remo Guerrini; E Reali; Roberto Tomatis; Maria Masucci; Serena Traniello
Effect of anchor residue modifications on the stability of HLA-A11/peptide complexes.
Biochemical and biophysical research communications 1995;206(1):8-14.
1994: M Matsuda; F Salazar; M Petersson; Giuseppe Masucci; J Hansson; Pavel Pisa; Q J Zhang; Maria Masucci; Rolf Kiessling
Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.
The Journal of experimental medicine 1994;180(6):2371-6.
1994: H Nakagomi; Riccardo Dolcetti; Maria Teresa Bejarano; Pavel Pisa; Rolf Kiessling; Maria Masucci
The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines.
International journal of cancer. Journal international du cancer 1994;57(2):240-4.
1994: Maria Masucci; I Ernberg
Epstein-Barr virus: adaptation to a life within the immune system.
Trends in microbiology 1994;2(4):125-30.
1994: P O de Campos-Lima; Victor Levitsky; J Brooks; S P Lee; L F Hu; Alan B Rickinson; Maria Masucci
T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues.
The Journal of experimental medicine 1994;179(4):1297-305.
1994: Pankaj Trivedi; L F Hu; F Chen; B Christensson; Maria Masucci; George Klein; Gösta Winberg
Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue.
European journal of cancer (Oxford, England : 1990) 1994;30A(1):84-8.
1993: Maria Masucci
Viral immunopathology of human tumors.
Current opinion in immunology 1993;5(5):693-700.
1993: Maria Masucci; Riccardo Gavioli; P O de Campos-Lima; Q J Zhang; Pankaj Trivedi; Riccardo Dolcetti
Transformation-associated Epstein-Barr virus antigens as targets for immune attack.
Annals of the New York Academy of Sciences 1993;690():86-100.
1993: Pankaj Trivedi; L Cuomo; P O de Campos-Lima; Marta P Imreh; K Kvarnung; George Klein; Maria Masucci
Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
The Journal of general virology 1993;74 ( Pt 7)():1393-8.
1993: P O de Campos-Lima; Riccardo Gavioli; Q J Zhang; L E Wallace; Riccardo Dolcetti; M Rowe; Alan B Rickinson; Maria Masucci
HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population.
Science (New York, N.Y.) 1993;260(5104):98-100.
1993: L Cuomo; Q J Zhang; L Lombardi; S Torsteinsdottir; George Klein; R Dalla-Favera; Maria Masucci
Over-expression of C-myc increases the sensitivity of Epstein-Barr virus immortalized lymphoblastoid cells to non-MHC-restricted cytotoxicity.
International journal of cancer. Journal international du cancer 1993;53(6):1008-12.
1993: T Nilsson; A Sjöblom; Maria Masucci; Lars Rymo
Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
Virology 1993;193(2):774-85.
1993: L Cuomo; Pankaj Trivedi; P O de Campos-Lima; Q J Zhang; E Ragnar; George Klein; Maria Masucci
Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.
Molecular immunology 1993;30(5):441-50.
1993: Q J Zhang; Riccardo Gavioli; George Klein; Maria Masucci
An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(6):2217-21.
1993: P O de Campos-Lima; S Torsteinsdóttir; L Cuomo; George Klein; D Sulitzeanu; Maria Masucci
Antigen processing and presentation by EBV-carrying cell lines: cell-phenotype dependence and influence of the EBV-encoded LMP1.
International journal of cancer. Journal international du cancer 1993;53(5):856-62.
1993: Riccardo Gavioli; Michael Kurilla; P O de Campos-Lima; L E Wallace; Riccardo Dolcetti; R J Murray; Alan B Rickinson; Maria Masucci
Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.
Journal of virology 1993;67(3):1572-8.
1992: Lars-Gunnar Larsson; Fredrik Oberg; P Stöckbauer; Maria Masucci; Kenneth Nilsson
Suppression of basal, PMA- and IFN-alpha-, but not IFN-gamma-induced expression of HLA class I in v-myc-transformed U-937 monoblasts.
International journal of cancer. Journal international du cancer 1992;52(5):759-65.
1992: Maria Masucci; Q J Zhang; Riccardo Gavioli; P O De Campos-Lima; R J Murray; J Brooks; H Griffin; H Ploegh; Alan B Rickinson
Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
International immunology 1992;4(11):1283-92.
1992: L Cuomo; T Ramquist; Pankaj Trivedi; F Wang; George Klein; Maria Masucci
Expression of the Epstein-Barr virus (EBV)-encoded membrane protein LMP1 impairs the in vitro growth, clonability and tumorigenicity of an EBV-negative Burkitt lymphoma line.
International journal of cancer. Journal international du cancer 1992;51(6):949-55.
1992: Riccardo Gavioli; P O De Campos-Lima; Michael Kurilla; Elliott Kieff; George Klein; Maria Masucci
Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(13):5862-6.
1992: Gerald Niedobitek; Hermann Herbst; Lawrence S Young; L Brooks; Maria Masucci; J Crocker; A B Rickinson; Harald Stein
Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue.
Blood 1992;79(10):2520-6.
1992: Ann Jansson; Maria Masucci; Lars Rymo
Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines.
Journal of virology 1992;66(1):62-9.
1992: Alan B Rickinson; R J Murray; J Brooks; H Griffin; Denis Moss; Maria Masucci
T cell recognition of Epstein-Barr virus associated lymphomas.
Cancer surveys 1992;13():53-80.
1991: B A Contreras-Brodin; M Anvret; Stefan Imreh; ENDER ALTIOK; George Klein; Maria Masucci
B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids.
The Journal of general virology 1991;72 ( Pt 12)():3025-33.
1991: S Torsteinsdottir; L Cuomo; Eva Klein; Maria Masucci
Stimulation with allogeneic Epstein-Barr virus-transformed lymphoblastoid cell lines generates HLA class I-specific CTLs with different target cell avidity.
Cellular immunology 1991;137(2):501-13.
1991: Pankaj Trivedi; Maria Masucci; Gösta Winberg; George Klein
The epstein-Barr-virus-encoded membrane protein LMP but not the nuclear antigen EBNA-1 induces rejection of transfected murine mammary carcinoma cells.
International journal of cancer. Journal international du cancer 1991;48(5):794-800.
1991: M L Andersson; N J Stam; George Klein; H L Ploegh; Maria Masucci
Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells.
International journal of cancer. Journal international du cancer 1991;47(4):544-50.
1991: Maria Masucci; Eva Klein
Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines.
Seminars in cancer biology 1991;2(1):63-71.
1991: Anders Osterborg; Maria Masucci; S Bergenbrant; Göran Holm; Ann Kari Lefvert; Håkan Mellstedt
Generation of T cell clones binding F(ab')2 fragments of the idiotypic immunoglobulin in patients with monoclonal gammopathy.
Cancer immunology, immunotherapy : CII 1991;34(3):157-62.
1991: J Avila-Cariño; S Torsteinsdottir; Barbro Ehlin-Henriksson; Maria Masucci; Eva Klein
Search for the critical characteristics of phenotypically different B cell lines, Burkitt lymphoma cells and lymphoblastoid cell lines, which determine differences in their functional interaction with allogeneic lymphocytes.
Cancer immunology, immunotherapy : CII 1991;34(2):128-32.
1990: B Contreras-Salazar; Barbro Ehlin-Henriksson; George Klein; Maria Masucci
Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection.
Journal of virology 1990;64(11):5441-7.
1990: L Cuomo; Pankaj Trivedi; F Wang; Gösta Winberg; George Klein; Maria Masucci
Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
European journal of immunology 1990;20(10):2293-9.
1990: Maria Teresa Bejarano; Maria Masucci; A Morgan; B Morein; George Klein; Eva Klein
Epstein-Barr virus (EBV) antigens processed and presented by B cells, B blasts, and macrophages trigger T-cell-mediated inhibition of EBV-induced B-cell transformation.
Journal of virology 1990;64(3):1398-401.
1990: Hans-Gustaf Ljunggren; M Oudshoorn-Snoek; Maria Masucci; H L Ploegh
High-resolution one-dimensional isoelectric focusing of mouse MHC class I antigens. Identification of natural and experimentally induced class I antigens.
Immunogenetics 1990;32(6):440-50.
1990: Maria Masucci
Cell phenotype dependent down-regulation of MHC class I antigens in Burkitt's lymphoma cells.
Current topics in microbiology and immunology 1990;166():309-16.
1989: Ingemar Ernberg; K Falk; J Minarovits; Pierre Busson; T Tursz; Maria Masucci; George Klein
The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
The Journal of general virology 1989;70 ( Pt 11)():2989-3002.
1989: Maria Masucci; B Contreras-Salazar; E Ragnar; K Falk; J Minarovits; Ingemar Ernberg; George Klein
5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael.
Journal of virology 1989;63(7):3135-41.
1989: Giuseppe Masucci; Håkan Mellstedt; G Henle; W Henle; Lars Rymo; Maria Masucci; I Ernberg; George Klein
Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients.
International journal of cancer. Journal international du cancer 1989;43(6):1017-21.
1989: B Contreras-Salazar; George Klein; Maria Masucci
Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids.
Journal of virology 1989;63(6):2768-72.
1989: Maria Masucci; N J Stam; S Torsteinsdottir; Jacques Neefjes; George Klein; H L Ploegh
Allele-specific down-regulation of MHC class I antigens in Burkitt lymphoma lines.
Cellular immunology 1989;120(2):396-400.
1989: S Torsteinsdóttir; M L Andersson; J Avila-Cariño; Barbro Ehlin-Henriksson; Maria Masucci; George Klein; Eva Klein
Reversion of tumorigenicity and decreased agarose clonability after EBV conversion of an IgH/myc translocation-carrying BL line.
International journal of cancer. Journal international du cancer 1989;43(2):273-8.
1988: J Avila-Carino; S Torsteinsdottir; Maria Teresa Bejarano; George Klein; Eva Klein; Maria Masucci
Combined treatment with interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines.
Cellular immunology 1988;117(2):303-11.
1988: G V Patel; Maria Masucci; Gösta Winberg; George Klein
Expression of the Epstein-Barr virus encoded EBNA-1 gene in stably transfected human and murine cell lines.
International journal of cancer. Journal international du cancer 1988;42(4):592-8.
1988: Maria Teresa Bejarano; Maria Masucci; George Klein; Eva Klein
T-cell-mediated inhibition of EBV-induced B-cell transformation: recognition of virus particles.
International journal of cancer. Journal international du cancer 1988;42(3):359-64.
1988: S Torsteinsdottir; C Brautbar; George Klein; Eva Klein; Maria Masucci
Differential expression of HLA antigens on human B-cell lines of normal and malignant origin: a consequence of immune surveillance or a phenotypic vestige of the progenitor cells?
International journal of cancer. Journal international du cancer 1988;41(6):913-9.
1987: J Avila-Cariño; S Torsteinsdottir; Barbro Ehlin-Henriksson; G Lenoir; George Klein; Eva Klein; Maria Masucci
Paired Epstein-Barr virus (EBV)-negative and EBV-converted Burkitt lymphoma lines: stimulatory capacity in allogeneic mixed lymphocyte cultures.
International journal of cancer. Journal international du cancer 1987;40(5):691-7.
1987: Ada Hatzubai; M Anafi; Maria Masucci; J Dillner; R A Lerner; G Klein; D Sulitzeanu
Down-regulation of the EBV-encoded membrane protein (LMP) in Burkitt lymphomas.
International journal of cancer. Journal international du cancer 1987;40(3):358-64.
1987: M T Bejarano; S Thorsteinsdottir; J P Andersson; U G Andersson; Maria Masucci; R Szigeti; E Klein; G Klein
Defective cell-mediated response to EBV-transformed B cells in a healthy individual with regular EBV antibody titers.
International journal of cancer. Journal international du cancer 1987;40(2):149-56.
1987: Maria Masucci; S Torsteindottir; J Colombani; C Brautbar; E Klein; G Klein
Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(13):4567-71.
1987: Maria Masucci; R Szigeti; I Ernberg; C P Hu; S Torsteinsdottir; R Frade; E Klein
Activation of B lymphocytes by Epstein-Barr virus/CR2 receptor interaction.
European journal of immunology 1987;17(6):815-20.
1987: N Lewin; P Aman; Maria Masucci; E Klein; G Klein; B Oberg; H Strander; W Henle; G Henle
Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth.
International journal of cancer. Journal international du cancer 1987;39(4):472-6.
1987: Giuseppe Masucci; Håkan Mellstedt; Maria Masucci; I Ernberg; R Szigeti; G Henle; W Henle; G Klein
Analysis of Epstein-Barr virus-specific and non-specific immune functions in a patient during the development of a non-Hodgkin's lymphoma.
European journal of cancer & clinical oncology 1987;23(4):379-86.
1987: E Klein; S Torsteinsdottir; Maria Masucci
Allo-restricted cytotoxicity recognizing EBV-determined antigens. Comments.
The Journal of molecular and cellular immunology : JMCI 1987;3(3):195-7.
1986: M T Bejarano; Maria Masucci; E Klein
Differential effect of cyclosporin-A on the mixed-lymphocyte culture-induced proliferative and cytotoxic responses of T lymphocytes with different cell densities.
Cellular immunology 1986;103(2):409-16.
1986: S Torsteinsdottir; Maria Masucci; Barbro Ehlin-Henriksson; C Brautbar; H Ben Bassat; George Klein; Eva Klein
Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(15):5620-4.
1986: C P Hu; P Aman; Maria Masucci; E Klein; G Klein
B cell activation by the nontransforming P3HR-1 substrain of the Epstein-Barr virus (EBV).
European journal of immunology 1986;16(7):841-5.
1986: E Klein; S Torsteinsdottir; Maria Masucci; G Klein
Different sensitivity of B cell lines derived from Burkitt lymphoma (BL) and normal cells (LCL) to cytotoxic T cell clones generated by autologous and allogeneic stimulation.
Journal of immunogenetics 1986;13(2-3):269-74.
1986: S Torsteinsdottir; Maria Masucci; C Brautbar; G Lenoir; G Klein; E Klein
Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones.
Cellular immunology 1986;98(2):453-66.
1986: D Saranath; Maria Masucci; E Klein
Cytotoxic factor produced by human blood lymphocytes of low density upon exposure to autologous B cells.
Immunology letters 1986;12(2-3):141-6.
1985: M T Bejarano; Maria Masucci; E Klein
Specific and non-specific components in the triggering of proliferative and cytotoxic responses of T lymphocytes with different cell density.
Immunobiology 1985;170(3):175-91.
1985: M T Bejarano; Maria Masucci; I Ernberg; E Klein; G Klein
Effect of cyclosporin-A (CsA) on the ability of T lymphocyte subsets to inhibit the proliferation of autologous EBV-transformed B cells.
International journal of cancer. Journal international du cancer 1985;35(3):327-33.
1985: O F Ramos; Maria Masucci; E Klein
Modulation of human blood lymphocyte cytotoxicity by the phorbol ester tumor promoter P(Bu)2: increase of target binding, impairment of effector recycling, and activation of lytic potential which is independent of IL-2.
Cellular immunology 1985;91(1):178-92.
1985: R Szigeti; Maria Masucci; Giuseppe Masucci; P Aman; G Klein; E Klein
Leukocyte migration inhibitory factor production by activated lymphocytes representing immunological memory or virus-receptor interaction: response of T cell subsets to Epstein-Barr virus nuclear antigen, response of B cells to UV inactivated Epstein-Barr virus.
Immunology letters 1985;9(5):267-73.
1985: S Torsteinsdottir; Maria Masucci; Maria Teresa Bejarano; W Berthold; Eva Klein; George Klein
Selective inhibitory effect of Hu-IFN-gamma on the agarose clonability of tumor-derived lymphoid cell lines.
Cellular immunology 1985;90(1):65-73.
1984: Maria Masucci; S Torsteinsdottir; W Pear; A Carstensen; E Klein
Phorbol esters inhibit the functional activation of cytotoxic precursors in mixed lymphocyte cultures.
Journal of immunology (Baltimore, Md. : 1950) 1984;133(4):1755-62.
1984: Giuseppe Masucci; I Berkel; Maria Masucci; I Ernberg; R Szigeti; F Ersoy; Ozden Sanal; Olcay Yegin; G Henle; W Henle
Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patients.
Journal of clinical immunology 1984;4(5):369-82.
1984: S Torsteinsdottir; Maria Masucci; R Szigeti; A Bishara; C Brautbar; G Klein; E Klein
T lymphocyte culture established by repeated stimulation with the autologous lymphoblastoid line. MHC class II restricted interactions with B blasts.
Molecular biology & medicine 1984;2(4):285-99.
1984: S Torsteinsdottir; Maria Masucci; G Lenoir; G Klein; E Klein
Natural killer cell sensitivity of human lymphoid lines of B-cell origin does not correlate with tumorigenicity or with the expression of certain differentiation markers.
Cellular immunology 1984;86(2):278-86.
1984: Giuseppe Masucci; R Szigeti; D Stevens; Maria Masucci; E Klein; J Petersen; K Bendtzen; G Klein
Production of leukocyte migration inhibitory factor (LIF) in human lymphocyte subsets exposed to polyclonal activators.
Cellular immunology 1984;85(2):511-8.
1984: E Klein; F Vánky; Maria Masucci; M T Bejarano
Experimental and clinical data for the role of NK-cells in immunosurveillance.
Behring Institute Mitteilungen 1984;(74):140-8.
1984: O F Ramos; Maria Masucci; E Klein
Activation of cytotoxic activity of human blood lymphocytes by tumor-promoting compounds.
Cancer research 1984;44(5):1857-62.
1984: Giuseppe Masucci; Håkan Mellstedt; Maria Masucci; R Szigeti; I Ernberg; M Björkholm; K Tsukuda; G Henle; W Henle; G Pearson
Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Cancer research 1984;44(3):1288-300.
1984: E Svedmyr; I Ernberg; J Seeley; O Weiland; Giuseppe Masucci; K Tsukuda; R Szigeti; Maria Masucci; H Blomogren; W Berthold
Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis.
Clinical immunology and immunopathology 1984;30(3):437-50.
1984: F Vánky; Maria Masucci; M T Bejarano; E Klein
Lysis of tumor biopsy cells by blood lymphocyte subsets of various densities. Autologous and allogeneic studies.
International journal of cancer. Journal international du cancer 1984;33(2):185-92.
1983: O F Ramos; Maria Masucci; M T Bejarano; E Klein
The tumor promoter phorbol-12,13-dibutyrate [P(Bu)2] stimulates cytotoxic activity of human blood lymphocytes.
Immunobiology 1983;165(5):403-14.
1983: G Masucci; Maria Masucci; M T Bejarano; E Klein
Comparison of highly NK active human lymphocyte subsets separated by various procedures involving E, EA rosetting, density gradients and adherence to immune complexes.
Journal of immunological methods 1983;63(1):57-67.
1983: Maria Masucci; E Klein
Role of T cell subpopulations in the control of the proliferative potential of EBV transformed B cells.
Behring Institute Mitteilungen 1983;(72):163-8.
1983: Maria Masucci; M T Bejarano; G Masucci; E Klein
Large granular lymphocytes inhibit the in vitro growth of autologous Epstein-Barr virus-infected B cells.
Cellular immunology 1983;76(2):311-21.
1982: E Klein; Maria Masucci; G Masucci; F Vánky
Natural killer activity of human blood lymphocytes.
Molecular immunology 1982;19(10):1323-9.
1982: R Szigeti; E Klein; Maria Masucci; I Ernberg; Giuseppe Masucci; E Svedmyr; G Klein
[Leukocyte migration inhibition elicited by Epstein-Barr virus antigen. Reaction potential in infectious mononucleosis as well as in states of immune deficiency and immunosuppression].
Orvosi hetilap 1982;123(20):1217-21.
1982: G Masucci; Maria Masucci; E Klein
Human blood lymphocyte subsets separated on the basis of nylon adherence, SRBC and EA rosetting: natural cytotoxicity and characterization with monoclonal reagents.
Cellular immunology 1982;69(1):166-74.
1982: G Masucci; Maria Masucci; E Klein
Activation of human blood lymphocyte subsets for cytotoxic potential.
Cellular immunology 1982;69(1):21-33.
1982: Y Wu; I Ernberg; Maria Masucci; D Johnson; E Klein; G Klein
Human T cell growth factor (TCGF) produced by repeated stimulation of non-adherent human lymphocytes.
Journal of immunological methods 1982;51(1):35-44.
1982: F Vánky; T Gorsky; Y Gorsky; Maria Masucci; E Klein
Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.
The Journal of experimental medicine 1982;155(1):83-95.
1982: E Klein; Maria Masucci
Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.
Springer seminars in immunopathology 1982;5(1):63-73.
1982: R Szigeti; Maria Masucci; W Henle; G Henle; D Purtilo; G Klein
Effect of different Epstein-Barr virus-determined antigens (EBNA, EA, and VCA) on the leukocyte migration of healthy donors and patients with infectious mononucleosis and certain immunodeficiencies.
Clinical immunology and immunopathology 1982;22(1):128-38.
1981: Maria Masucci; R Szigeti; I Ernberg; M Björkholm; Håkan Mellstedt; G Henle; W Henle; G Pearson; Giuseppe Masucci; E Svedmyr; B Johansson; G Klein
Cell-mediated immune reactions in three patients with malignant lymphoproliferative diseases in remission and abnormally high Epstein-Barr virus antibody titers.
Cancer research 1981;41(11 Pt 1):4292-301.
1981: E Klein; I Ernberg; Maria Masucci; R Szigeti; Y T Wu; Giuseppe Masucci; E Svedmyr
T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
Cancer research 1981;41(11 Pt 1):4210-5.
1981: Maria Masucci; R Szigeti; I Ernberg; Giuseppe Masucci; G Klein; J Chessels; C Sieff; S Lie; A Glomstein; L Businco; W Henle; G Henle; G Pearson; K Sakamoto; D T Purtilo
Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
Cancer research 1981;41(11 Pt 1):4284-91.
1981: R Szigeti; D Stevens; I Ernberg; G Klein; Maria Masucci; E Svedmyr; E Klein
Use of cryopreserved lymphocytes for the indirect leukocyte migration inhibition assay.
Journal of immunological methods 1981;46(3):369-74.
1980: R Szigeti; Maria Masucci; Giuseppe Masucci; E Klein; G Klein
Interferon suppresses antigen- and mitogen-induced leukocyte migration inhibition.
Nature 1980;288(5791):594-6.
1980: Maria Masucci; R Szigeti; E Klein; G Klein; J Gruest; Luc Montagnier; H Taira; A Hall; S Nagata; C Weissmann
Effect of interferon-alpha 1 from E. coli on some cell functions.
Science (New York, N.Y.) 1980;209(4463):1431-5.
1980: Maria Masucci; Giuseppe Masucci; E Klein; W Berthold
Target selectivity of interferon-induced human killer lymphocytes related to their Fc receptor expression.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(6):3620-4.
1980: Maria Masucci; E Klein; S Argov
Disappearance of the NK effect after explantation of lymphocytes and generation of similar nonspecific cytotoxicity correlated to the level of blastogenesis in activated cultures.
Journal of immunology (Baltimore, Md. : 1950) 1980;124(5):2458-63.